Results 101 to 110 of about 65,249 (309)

Obstacles and Considerations Related to Clinical Trial Research During the COVID-19 Pandemic

open access: yesFrontiers in Medicine, 2020
The response to the COVID-19 pandemic from the research and science community has been vigorous, with information being released faster than that of any other event in human history.
Hasan Hashem   +3 more
doaj   +1 more source

Download the full PDF of Jefferson Surgical Solutions Spring 2009, Volume 4, Number 1. [PDF]

open access: yes, 2009
Download the full PDF of Jefferson Surgical Solutions Spring 2009, Volume 4, Number ...

core   +1 more source

Barriers and Enablers for Effective Support Coordination in the National Disability Insurance Scheme

open access: yesAustralian Journal of Social Issues, EarlyView.
ABSTRACT Support coordinators act as intermediaries between the National Disability Insurance Scheme (NDIS) and participants, facilitating access to funded supports. To optimise outcomes, they must navigate NDIS complexities, identify services that meet individual needs and engage with diverse stakeholders.
Sharyn McDonald   +3 more
wiley   +1 more source

Clinical and biochemical improvements in a patient with MNGIE following enzyme replacement. [PDF]

open access: yes, 2013
Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is a rare autosomal recessive metabolic disorder caused by a deficiency of thymidine phosphorylase (TP, EC2.4.2.4) due to mutations in the nuclear gene TYMP.
Bain, MD   +5 more
core   +1 more source

How Are Australian Local Governments Responding to the Homelessness Crisis? Findings From a National Study

open access: yesAustralian Journal of Social Issues, EarlyView.
ABSTRACT Australian local governments are facing intensifying pressures to respond to worsening visible homelessness. This paper presents one of the first national studies on how local governments are responding to these pressures, and the first since the onset of the post‐pandemic housing crisis.
Andrew Clarke   +3 more
wiley   +1 more source

Chief Justice Robots [PDF]

open access: yes, 2019
Say an AI program someday passes a Turing test, because it can con-verse in a way indistinguishable from a human. And say that its develop-ers can then teach it to converse—and even present an extended persua-sive argument—in a way indistinguishable from
Volokh, Eugene
core   +1 more source

Interleukin‐2 Deprived State of Regulatory T cells and Their Recovery by Low‐Dose Interleukin‐2 in Patients With Inflammatory Myopathies

open access: yesArthritis &Rheumatology, EarlyView.
Objective Regeneration and expansion of Treg by low‐dose interleukin‐2 (IL‐2) therapy is considered a potential treatment strategy for a wide range of autoimmune diseases. To provide a pathophysiologically‐based rationale for low‐dose IL‐2 therapy, we investigated whether reversible defects in the Treg–IL‐2 axis emerge in inflammatory myopathies ...
Justus Ohmes   +10 more
wiley   +1 more source

Anti-interleukin-5 therapy (mepolizumab) in life-threatening asthma attack: A case-based discussion

open access: yesRespiratory Medicine Case Reports, 2019
We report about a case of a compassionate off-label use of the anti-interleukin-5-agent mepolizumab in a ventilated patient with life-threatening asthma attack in eosinophilic asthma.
Khodr Tello   +12 more
doaj   +1 more source

The emerging role of Buddhism in clinical psychology: Toward effective integration. [PDF]

open access: yes, 2014
Research into the clinical utility of Buddhist-derived interventions (BDIs) has increased greatly over the last decade. While clinical interest has predominantly focused on mindfulness meditation, there has also been an increase in the scientific ...
Griffiths, MD, Shonin, E, Van Gordon, W
core   +1 more source

How we approach early phase clinical trial and off-label therapy consults in pediatric oncology: The New Agents and Innovative Therapy (NAIT) team experience

open access: yesEJC Paediatric Oncology
In the context of hard-to-cure disease, pediatric oncologists may have to explore novel therapy options and explain their rationale, risks and constraints to patients and caregivers.
Gabriel Revon-Rivière   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy